Literature DB >> 17532938

Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.

Morihito Okada1, Shunsuke Tauchi, Koichiro Iwanaga, Takeshi Mimura, Yoshitaka Kitamura, Hirokazu Watanabe, Shuji Adachi, Toshiko Sakuma, Chiho Ohbayashi.   

Abstract

OBJECTIVE: The aggressiveness of small adenocarcinomas has not been fully evaluated using integrated positron emission tomography/computed tomography. We investigated malignant aggressiveness according to positron emission tomography/computed tomography, high-resolution computed tomographic findings, and the proportions of pathologically defined bronchioloalveolar carcinomas in cT1N0M0 lung adenocarcinoma.
METHODS: Sixty consecutive patients with cT1N0M0 lung adenocarcinomas of 3 cm or less in diameter underwent fluorodeoxyglucose-positron emission tomograph/computed tomography, and high-resolution computed tomography, followed by complete tumor resection. Correlations between the proportion of bronchioloalveolar carcinoma and maximum standardized uptake value on positron emission tomographic scan/computed tomographic scan, ground-glass opacity, and tumor shadow disappearance rate were investigated and the findings were compared with clinicopathologic features.
RESULTS: Lymphatic and vascular invasion occurred in 18 (30%) and 13 (22%) patients, respectively, whereas hilar or mediastinal lymph nodes occurred in 8 patients (13%). Maximum standardized uptake value generally seemed the most valuable predictor of lymphatic invasion, vascular invasion, and nodal metastasis compared with ground-glass opacity, tumor shadow disappearance rate, and bronchioloalveolar carcinoma ratios. Although the association was significant between the bronchioloalveolar carcinoma ratio versus maximum standardized uptake value, ground-glass opacity ratio, and tumor shadow disappearance rate (all P < .0001), maximum standardized uptake value (R2 = 0.245) was less correlated with the bronchioloalveolar carcinoma ratio than was the ground-glass opacity ratio (R2 = 0.554) and tumor shadow disappearance rate (R2 = 0.671).
CONCLUSIONS: The malignant behavior of small adenocarcinomas with a lower maximum standardized uptake value and a greater proportion of ground-glass opacity, tumor shadow disappearance rate, and bronchioloalveolar carcinoma was less aggressive. Maximum standardized uptake value was a more powerful clinical predictor of biologic tumor performance, independent of pathologic bronchioloalveolar carcinoma proportion. Preoperative assessment of maximum standardized uptake value on positron emission tomographic/computed tomographic findings, in addition to the ground-glass opacity ratio and tumor shadow disappearance rate on high-resolution computed tomographic scans, might be useful to guide treatment strategies for small adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532938     DOI: 10.1016/j.jtcvs.2007.02.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.

Authors:  Masaya Tamura; Makoto Oda; Isao Matsumoto; Yosuke Shimizu; Ryuichi Waseda; Go Watanabe
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

2.  Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: a propensity-matched study.

Authors:  Tomohiro Murakawa; Junji Ichinose; Haruaki Hino; Kentaro Kitano; Chihiro Konoeda; Jun Nakajima
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.

Authors:  Jun-Ichi Nitadori; Adam J Bograd; Eduardo A Morales; Nabil P Rizk; Mark P S Dunphy; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli
Journal:  Ann Surg Oncol       Date:  2013-08-17       Impact factor: 5.344

4.  Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma.

Authors:  Morihito Okada; Takahiro Mimae; Yasuhiro Tsutani; Haruhiko Nakayama; Sakae Okumura; Masahiro Yoshimura; Yoshihiro Miyata
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

Review 6.  Management of CT screen-detected lung nodule: the thoracic surgeon perspective.

Authors:  Adnan M Al-Ayoubi; Raja M Flores
Journal:  Ann Transl Med       Date:  2016-04

7.  The impact on the prognosis of unsuspected N2 disease in non-small-cell lung cancer: indications for thorough mediastinal staging in the modern era.

Authors:  Ryosuke Tachi; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2016-07-21       Impact factor: 2.549

8.  Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.

Authors:  Kotaro Higashi; Tsutomu Sakuma; Kengo Ito; Seiji Niho; Yoshimichi Ueda; Takeshi Kobayashi; Ryuzo Sekiguchi; Tomoko Takahashi; Takashi Kato; Hisao Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-18       Impact factor: 9.236

Review 9.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Assessment of relationships among clinicopathological characteristics, morphological computer tomography features, and tumor cell proliferation in stage I lung adenocarcinoma.

Authors:  Xiaoling Ma; Shuchang Zhou; Lu Huang; Peijun Zhao; Yujin Wang; Qiongjie Hu; Liming Xia
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.